|
HLA-DRB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.897370E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.858240E-01 |
| Normal-vs-Stage2 |
9.883600E-02 |
| Normal-vs-Stage3 |
8.152200E-02 |
| Normal-vs-Stage4 |
7.435600E-02 |
| Stage1-vs-Stage2 |
1.97049999999255E-05 |
| Stage1-vs-Stage3 |
4.885000E-01 |
| Stage1-vs-Stage4 |
3.317200E-01 |
| Stage2-vs-Stage3 |
1.70214999999363E-05 |
| Stage2-vs-Stage4 |
1.193570E-04 |
| Stage3-vs-Stage4 |
6.540800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.846400E-02 |
| Normal-vs-AfricanAmerican |
4.952600E-01 |
| Normal-vs-Asian |
2.858400E-01 |
| Caucasian-vs-AfricanAmerican |
6.665000E-01 |
| Caucasian-vs-Asian |
7.102000E-01 |
| AfricanAmerican-vs-Asian |
8.831800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.049200E-01 |
| Normal-vs-Female |
1.603550E-01 |
| Male-vs-Female |
4.941400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.925780E-01 |
| Normal-vs-Age(41-60Yrs) |
2.241000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.943200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.774400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.629800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.281200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.318800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.951000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.004600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.616640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.197500E-04 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
7.557100E-04 |
| Classical-VS-Normal |
9.124300E-02 |
| Tall-VS-Follicular |
5.16389997429201E-09 |
| Tall-VS-Other |
5.07909999947209E-07 |
| Tall-VS-Normal |
1.849150E-04 |
| Follicular-VS-Other |
4.214800E-01 |
| Follicular-VS-Normal |
6.459300E-03 |
| Other-VS-Normal |
1.128170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.252000E-01 |
| Normal-vs-N1 |
4.474800E-01 |
| N0-vs-N1 |
5.879400E-01 |
|
|
